Oct 14
|
Pfizer drug for hemophilia approved by FDA
|
Oct 14
|
FDA Approves Pfizer's Second Hemophilia Drug With Six Months
|
Oct 14
|
Prediction: These 2 High-Yield Dividend Stocks Will Outperform the S&P 500 Index in the Coming Decade
|
Oct 14
|
FDA approves Pfizer’s HYMPAVZI to treat haemophilia
|
Oct 12
|
The past three years for Pfizer (NYSE:PFE) investors has not been profitable
|
Jul 29
|
Pfizer Stock Is on a Hot Streak. Earnings Could Determine Its Next Move.
|
Jul 29
|
Wall Street is still jittery on GLP-1s
|
Jul 29
|
Prediction: This Will Be Pfizer's Next Big Move
|
Jul 29
|
Big Pharma Rallies and Moves Past Obesity
|
Jul 29
|
RSV vaccine makers vying for market share in second year of shots
|
Jul 29
|
3 Ultra-High-Yield Dividend Stocks to Buy Now and Hold Forever
|
Jul 28
|
2 Incredibly Cheap Healthcare Stocks to Buy Now
|
Jul 27
|
2 High-Yield Dividend Stocks That Could Shine in 2025
|
Jul 27
|
2 Unstoppable Growth Stocks to Buy Right Now for Less Than $200
|
Jul 26
|
Big Tech earnings, jobs report, Fed decision: What to Watch
|
Jul 26
|
3 Surprisingly Underrated Stocks to Buy Right Now
|
Jul 26
|
Pharma Stock Roundup: AZN, SNY, ABBV Q2 Earnings, PFE & MRK's Positive Pipeline News
|
Jul 26
|
Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know
|
Jul 26
|
EC conditionally approves Pfizer’s haemophilia B gene therapy
|
Jul 26
|
This Biotech Risk-Taker Created Moderna. Now He’s Harnessing AI.
|